Mustaqueem Pallumeera

Mr. Mustaqueem Pallumeera

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MPMustaqueem Pallumeera
Mustaqueem Pallumeera
JGJonathan Chungheng Giang
Jonathan Chungheng Giang
RSRamanpreet Singh
Ramanpreet Singh
NPNooruddin Pracha
Nooruddin Pracha
MMMina S Makary
Mina S Makary
Artificial intelligence (AI) is revolutionizing cancer imaging, enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications, particularly deep learning and machine learning, excel in risk assessment, tumor detection, classification, and predictive treatment prognosis. Machine learning algorithms, especially deep learning frameworks, improve lesion characterization and automated segmentation, leading to enhanced radiomic feature extraction and delineation. Radiomics, which quantifies imaging features, offers personalized treatment response predictions across various imaging modalities. AI models also facilitate technological improvements in non-diagnostic tasks, such as image optimization and automated medical reporting. Despite advancements, challenges persist in integrating AI into healthcare, tracking accurate data, and ensuring patient privacy. Validation through clinician input and multi-institutional studies is essential for patient safety and model generalizability. This requires support from radiologists worldwide and consideration of complex regulatory processes. Future directions include elaborating on existing optimizations, integrating advanced AI techniques, improving patient-centric medicine, and expanding healthcare accessibility. AI can enhance cancer imaging, optimizing precision medicine and improving patient outcomes. Ongoing multidisciplinary collaboration between radiologists, oncologists, software developers, and regulatory bodies is crucial for AI’s growing role in clinical oncology. This review aims to provide an overview of the applications of AI in oncologic imaging while also discussing their limitations.

22 December 2023 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
HSHania Shahzad
Hania Shahzad
PAPaul M. Alvarez
Paul M. Alvarez
MPMustaqueem Pallumeera
Mustaqueem Pallumeera
NBNazihah Bhatti
Nazihah Bhatti
EYElizabeth Yu
Elizabeth Yu
VSVarun K. Singh
Varun K. Singh
Patients with long-term follow-up after cervical decompression and fusion have often been noted to have development of adjacent segment degeneration with a smaller subset of these patients progressing to adjacent segment disease (ASD), which results in the development of new symptomatic radiculopathy or myelopathy referable to a site either directly above or below a prior fused segment. The cause of ASD is multifactorial often involving natural age-related progression of spondylosis, accelerated progression following cervical decompression and fusion, operative technique, and patient-related factors. The effect of age at the time of index cervical decompression and fusion on the need for reoperation for ASD is not fully understood. This study aims to establish underlying risk factors for the development of symptomatic cervical ASD following cervical decompression and fusion requiring reoperation in patients of various age groups. A retrospective database review of patients aged 20 or greater with insurance claims of primary cervical decompression and fusion over the course of 11 years and 10 months (January 01, 2010–October 31, 2022) was conducted using an insurance claims database. The primary outcome was to evaluate the incidence of cervical ASD requiring reoperation amongst patients stratified by age at the time of their primary procedure. Secondary outcomes included an evaluation of various risk factors for ASD following cervical decompression and fusion including surgeon-controlled factors such as the number of levels fused and approach taken, patient cervical pathology including cervical disc disorder and cervical spondylosis, and underlying patient medical comorbidities including osteoporosis and vitamin D deficiency, and substance use. A total of 60,292 patient records were analyzed, where the overall reoperation incidence for symptomatic ASD was 6.57%, peaking at 8.12% among those aged 30 to 39 and decreasing with age. Regression analysis revealed ages lower than 50 years as more predictive for the development of symptomatic ASD requiring reoperation. Multivariate regression analysis identified predictive factors for reoperation, including age, Elixhauser Comorbidity Index (ECI), multiple-level surgery, cervical spondylosis, cervical disc disorder, osteoporosis, and vitamin D deficiency. Notably, these factors had a variable impact across various age groups, as revealed by subgroup analysis. The incidence of reoperation secondary to symptomatic ASD is 6.57%, highest in those aged 30 to 39. The surgical approach had no significant impact on the need for reoperation, but multiple-level fusions posed a consistent risk in the development of symptomatic ASD requiring reoperation. Patient factors like degenerative disc disease, spondylosis, osteoporosis, and vitamin D deficiency were associated, urging further age-specific risk assessment and nonoperative intervention exploration.

19 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MPMustaqueem Pallumeera
Mustaqueem Pallumeera
MHMarcus Hong
Marcus Hong
JGJonathan Chungheng Giang
Jonathan Chungheng Giang
MMMina S Makary
Mina S Makary
Histotripsy is a novel, non-invasive ultrasound-based ablative therapy that destroys tissue through focused cavitation. As solid tumors continue to be a major global health burden, there is interest in image-guided ablation techniques that reduce collateral damage and promote immune activation. This narrative review aims to synthesize current advancements, clinical applications, limitations, and future directions of histotripsy in both oncologic and non-oncologic contexts. A comprehensive literature search was conducted from database inception to July 2025. Search terms included combinations of subject headings and keywords such as “histotripsy,” “mechanical ablation,” “ultrasound,” and “solid tumors.” Boolean operators and truncation were used to increase sensitivity. Peer-reviewed studies were included, encompassing preclinical, clinical, and review articles. Reference lists of relevant articles were examined to identify additional sources. Histotripsy has shown strong potential in the treatment of tumors involving the liver, pancreas, kidney, brain, and cardiovascular system. It offers real-time imaging guidance, sharp lesion boundaries, and minimal damage to surrounding structures. Early clinical trials have demonstrated encouraging safety and efficacy, particularly in liver and kidney tumors. Its ability to preserve critical anatomy and stimulate innate and adaptive immune responses through the release of cellular debris and cytokines offers advantages over thermal ablation. Limitations include acoustic aberration, motion-related targeting challenges, and the need for further long-term clinical data. Histotripsy represents a promising advancement in noninvasive tumor ablation. Continued clinical investigation and technological refinement are necessary to validate its therapeutic value and define its role within comprehensive cancer care.

1 July 2023 in JBJS Reviews
Verified
Journal Article
Closed access
APAkshar V. Patel
Akshar V. Patel
ASAndrew J. Stevens
Andrew J. Stevens
NMNoah Mallory
Noah Mallory
DGDavid Gibbs
David Gibbs
MPMustaqueem Pallumeera
Mustaqueem Pallumeera
RRRyan C. Rauck
Ryan C. Rauck
» There is increased integration of machine learning (ML) to aid clinical decision-making in orthopaedic surgery. » ML has the ability to predict both clinical outcomes such as range of motion and complications in total shoulder arthroplasty patients. » An increased area of focus is the ability for ML to identify implants to aid in revision surgery planning. » In this article, we review the current applications of ML in shoulder arthroplasty and discuss future areas where it may enhance orthopaedic practice.

25 July 2024 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
GBGalo C. Bustamante
Galo C. Bustamante
EKErryk S. Katayama
Erryk S. Katayama
MPMustaqueem Pallumeera
Mustaqueem Pallumeera
LBLouis S. Barry
Louis S. Barry
JBJohn S. Barnett
John S. Barnett
RRRyan C. Rauck
Ryan C. Rauck